Prothena | PRTA - Current Assets



Prothena reported $385.48M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Acadia Pharmaceuticals USD 960.55M 89.61M Jun/2025
Agios Pharmaceuticals USD 1.02B 50.85M Jun/2025
ALKERMES USD 1.64B 156.24M Jun/2025
Alnylam Pharmaceuticals USD 3.64B 375.44M Jun/2025
Amgen USD 26.73B 195M Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
BioMarin Pharmaceutical USD 3.81B 337.43M Jun/2025
Exelixis USD 1.18B 215.74M Jul/2025
Incyte USD 3.64B 411.91M Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
MacroGenics USD 204.94M 12.55M Jun/2025
Neurocrine Biosciences USD 1.75B 111M Jun/2025
Prothena USD 385.48M 99.93M Jun/2025
Regeneron Pharmaceuticals USD 16.86B 712.2M Jun/2025
Ultragenyx Pharmaceutical USD 719.79M 20.63M Jun/2025
Vertex Pharmaceuticals USD 10.43B 419.1M Jun/2025